ICA-17043-10 Study Investigators. Improvements in Haemolysis and Indicators of Erythrocyte Survival Do Not Correlate with Acute Vaso-Occlusive Crises in Patients with Sickle Cell Disease: A Phase III Randomized, Placebo-Controlled, Double-Blind Study of the Gardos Channel Blocker Senicapoc (ICA-17043).

Academic Article

Author List

  • Goldman FD; Ataga KI; Reid M; Ballas SK; Yasin Z; Bigelow C; James LS; Smith WR; Galacteros F; Kutlar A
  • Start Page

  • 92
  • End Page

  • 104
  • Volume

  • 153
  • Issue

  • 1